{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-209439","form_type":"8-K","ticker":"RGEN","cik":"0000730272","company_name":"REPLIGEN CORP","filed_at":"2022-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.040738+00:00","generated_at":"2026-06-24T06:09:12.921586+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Repligen Q2 revenue $207.6M (+27% YoY); raises FY 2022 guidance","bullets":["Q2 revenue $207.6M, up 27% as reported, 32% constant currency; organic growth 29%.","GAAP diluted EPS $0.88 vs $0.64; adjusted EPS $0.91 vs $0.79, both YoY increases.","FY 2022 revenue guidance raised to $790-$810M from $770-$800M; adjusted EPS raised to $3.13-$3.20.","Base business grew 41% in Q2, led by Filtration and Chromatography franchises.","Cash $596.5M at June 30, 2022; gross margin 58.5% GAAP, 58.7% adjusted."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-209439","json":"https://secwatch.observer/filing/0001193125-22-209439.json","markdown":"https://secwatch.observer/filing/0001193125-22-209439.md","text":"https://secwatch.observer/filing/0001193125-22-209439.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/730272/000119312522209439/0001193125-22-209439-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/730272/000119312522209439/d371357d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T06:09:12.921586+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}